MilliporeSigma Invests $286-Million in Drug Safety Testing Capacity of the US
MilliporeSigma, Canada and US life science businesses of Merck KGaA, Germany, a leading science and technology company, announced that its life science business industry is investing over 286 million dollars in the biosafety testing capacity at the company’s site in Rockville, USA. This investment will significantly increase the ability of the company to conduct biosafety […]
Continue Reading